Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.

Auteurs Barr J, Caballería J, Martínez-Arranz I, Domínguez-Díez A, Alonso C, Muntané J, Pérez-Cormenzana M, García-Monzón C, Mayo R, Martín-Duce A, Romero-Gómez M, Lo Iacono O, Tordjman J, Andrade RJ, Pérez-Carreras M, Le Marchand-Brustel Y, Tran A, Fernández-Escalante C, Arévalo E, García-Unzueta M, Clement K, Crespo J, Gual P, Gómez-Fleitas M, Martínez-Chantar ML, Castro A, Lu SC, Vázquez-Chantada M, Mato JM

Journal of proteome research Apr 2012

Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues.

Auteurs Tomasello E, Yessaad N, Gregoire E, Hudspeth K, Luci C, Mavilio D, Hardwigsen J, Vivier E

Frontiers in immunology Jan 2012

The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease.

Auteurs Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, Le Marchand-Brustel Y, Veillon P, Calès P, Perlemuter G, Tran A, Gual P

PloS one Jan 2012

Natural killer cells and T cells induce different types of skin reactions during recall responses to haptens.

Auteurs Rouzaire P, Luci C, Blasco E, Bienvenu J, Walzer T, Nicolas JF, Hennino A

European journal of immunology Jan 2012

Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Auteurs Bihl F, Germain C, Luci C, Braud VM

Cellular and molecular life sciences : CMLS Nov 2011

C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.

Auteurs Zimmermann E, Anty R, Tordjman J, Verrijken A, Gual P, Tran A, Iannelli A, Gugenheim J, Bedossa P, Francque S, Le Marchand-Brustel Y, Clement K, Van Gaal L, Sørensen TIA, Jess T

Journal of hepatology Sep 2011

Hemojuvelin: a new link between obesity and iron homeostasis.

Auteurs Luciani N, Brasse-Lagnel C, Poli M, Anty R, Lesueur C, Cormont M, Laquerriere A, Folope V, LeMarchand-Brustel Y, Gugenheim J, Gual P, Tran A, Bekri S

Obesity (Silver Spring, Md.) Aug 2011

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

Auteurs Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F, Fang DD, Han T, Bailly-Maitre B, Poli V, Varki NM, Wang H, Feng GS

Cancer cell May 2011

Monocytes control natural killer cell differentiation to effector phenotypes.

Auteurs Soderquest K, Powell N, Luci C, van Rooijen N, Hidalgo A, Geissmann F, Walzer T, Lord GM, Martín-Fontecha A

Blood Apr 2011

Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.

Auteurs Lavallard VJ, Bonnafous S, Patouraux S, Saint-Paul MC, Rousseau D, Anty R, Le Marchand-Brustel Y, Tran A, Gual P

PloS one Mar 2011